fbpx

Systematic literature review of human studies assessing the efficacy of cannabidiol for social anxiety

The current review evaluates the potential of cannabidiol (CBD) as a promising pharmacotherapy for social anxiety disorder (SAD). Although a number of evidence-based treatments for SAD are available, less than a third of affected individuals experience symptom remission after one year of treatment. Therefore, improved treatment options are urgently needed, and CBD is one candidate medication that may have certain benefits over current pharmacotherapies, including the absence of sedating side effects, reduced abuse liability, and rapid course of action.

The post Systematic literature review of human studies assessing the efficacy of cannabidiol for social anxiety appeared first on Society of Cannabis Clinicians.

Leave a Reply

%d bloggers like this: